Cargando…

Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?

PURPOSE: Results from active surveillance trials for ductal carcinoma in situ (DCIS) will not be available for > 10 years. A model based on real-world data (RWD) can demonstrate the comparative impact of non-intervention for women with low-risk features. METHODS: Multi-state models were developed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Byng, Danalyn, Retèl, Valesca P., Schaapveld, Michael, Wesseling, Jelle, van Harten, Wim H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062323/ https://www.ncbi.nlm.nih.gov/pubmed/33389397 http://dx.doi.org/10.1007/s10549-020-06042-1

Ejemplares similares

Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists
por: Byng, Danalyn, et al.
Publicado: (2021)

Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study
por: Groen, Emma J., et al.
Publicado: (2020)

Active surveillance versus treatment in low-risk DCIS: Women’s preferences in the LORD-trial
por: Schmitz, Renée S.J.M., et al.
Publicado: (2023)

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
por: Elshof, Lotte E., et al.
Publicado: (2016)

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies
por: Rakovitch, E., et al.
Publicado: (2018)

Low-risk DCIS. What is it? Observe or excise?
por: Pinder, Sarah E., et al.
Publicado: (2021)

Early budget impact analysis on magnetic seed localization for non-palpable breast cancer surgery
por: Lindenberg, Melanie, et al.
Publicado: (2020)

Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer
por: van de Ven, Michiel, et al.
Publicado: (2022)

Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
por: Schmitz, Renée S J M, et al.
Publicado: (2023)

Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study
por: Mannu, Gurdeep S., et al.
Publicado: (2019)

Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness
por: Lindenberg, Melanie, et al.
Publicado: (2020)

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness
por: Lindenberg, Melanie, et al.
Publicado: (2022)

Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer
por: Groen, Emma J., et al.
Publicado: (2021)

Ductal carcinoma in situ (DCIS): are we overdetecting it?
por: Evans, A
Publicado: (2004)

Ductal carcinoma in situ (DCIS): are we overtreating it?
por: Dixon, JM
Publicado: (2004)

Epigenetic Alterations in DCIS Progression: What Can lncRNAs Teach Us?
por: Petrone, Igor, et al.
Publicado: (2023)

Scenario drafting to anticipate future developments in technology assessment
por: Retèl, Valesca P, et al.
Publicado: (2012)

Affordable Prices Without Threatening the Oncological R&D Pipeline—An Economic Experiment on Transparency in Price Negotiations
por: Franzen, Nora, et al.
Publicado: (2022)

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
por: van Roozendaal, L. M., et al.
Publicado: (2016)

Should we, can we, halt the rise in prescribing for pain and distress?
por: Byng, Richard
Publicado: (2020)

What can we learn from real world studies on direct oral anticoagulants?
por: Coppens, M.
Publicado: (2017)

Association between genomic recurrence risk and well-being among breast cancer patients
por: Retèl, Valesca P, et al.
Publicado: (2013)

Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients
por: Miquel-Cases, Anna, et al.
Publicado: (2016)

Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes
por: Lindenberg, Melanie A., et al.
Publicado: (2022)

Microcalcification crystallography as a potential marker of DCIS recurrence
por: Gosling, Sarah B., et al.
Publicado: (2023)

High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation
por: Verbeek, Joost G. E., et al.
Publicado: (2023)

Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?
por: Hahn, Ezra, et al.
Publicado: (2023)

Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada
por: Fatoye, Francis, et al.
Publicado: (2018)

Is palpable DCIS more aggressive than screen-detected DCIS?
por: Balac, Nina, et al.
Publicado: (2022)

Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis
por: van Amerongen, Rosa A, et al.
Publicado: (2016)

Liver cancer mortality over six decades in an epidemic area: what we have learned
por: Chen, Jian-Guo, et al.
Publicado: (2021)

A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy
por: Retèl, Valesca P, et al.
Publicado: (2011)

Emotions and decisions in the real world: What can we learn from quasi-field experiments?
por: Bhanot, Syon P., et al.
Publicado: (2020)

Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
por: Cserni, Gábor, et al.
Publicado: (2019)

Comparative analysis of methods for identifying multimorbidity patterns: a study of ‘real-world’ data
por: Roso-Llorach, Albert, et al.
Publicado: (2018)

Real‐world treatment patterns of sacubitril/valsartan: a longitudinal cohort study in Germany
por: Wachter, Rolf, et al.
Publicado: (2019)

Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry for a diverse US metropolitan population
por: Tannous, Jonika, et al.
Publicado: (2023)

In-hospital myocardial infarction and adherence to evidence-based drug therapies: a real-world evaluation
por: Soldati, Salvatore, et al.
Publicado: (2021)

Treatment With Tumor-infiltrating Lymphocytes in Advanced Melanoma: Evaluation of Early Clinical Implementation of an Advanced Therapy Medicinal Product
por: Lindenberg, Melanie A., et al.
Publicado: (2018)

Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast
por: Jia, Huiqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b704ajioa7tb9a02e48vaqd99c